home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Formulation & Drug Delivery USA Congress

 
  January 19, 2017  
     
 
Oxford Global, Boston, USA
14 - 15 September 2017


Oxford Global are proud to present our Formulation & Drug Delivery USA Congress, taking place on 14 – 15 September 2017 in Boston.
 
Over 150 delegates representing leading pharmaceutical organisations, biotech companies and internationally renowned research & academic institutions will be present to discuss and network. Over 40 case studies and presentations focused on exploring regulatory guidelines of both large and small molecule formulations, future applications of protein and peptide formulations, recent advancements in nanoparticles as drug delivery systems, combination drug delivery devices and improving the bioavailability of compounds.
 
Including 4 interactive streams:
  • Large Molecule Drug Formulation
  • Small Molecule Drug Delivery
  • Small Molecule Drug Formulation
  • Large Molecule Drug Delivery
Download Agenda Now: http://bit.ly/2iACg3K 
 
Free Live Webinar: ““To Flavor or not to Flavor an Extemporaneous Suspension Using Omeprazole as a Model Drug?””
Hosted by Monica Chuong, Associate Professor, Massachusetts College of Pharmacy and Health Sciences
Register for Free Today: http://bit.ly/2j3NPnk 
 
Free Webinar Recording
Advances in Small Drugs Formulation Research
Hosted by David Elder, Director, Product Development, GlaxoSmithKline and René Holm, Senior Director, Pharmaceutical Science, H. Lundbeck A/S
Download for Free Today: http://bit.ly/2gZey08 
 
For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.

 
 
Organized by: Oxford Global
Invited Speakers:
  • Robert McKean VP, US CMC Pharmaceutical Development Discovery and Product Development, Global R&D, Teva
  • Pradeep Dhal, Senior Scientific Director, Genzyme Corporation
  • Adrian Gilbert, Vice President, Speciality CMC IL, DIscovery & Product Development, Teva Global R&D
  • Advait Badkar, Senior Director, Pfizer
  • Chris Ho, Scientific Director, Formulation Development (Pharmaceutical Development Science), Genzyme
 
Deadline for Abstracts: N/A
 
Registration: For further information regarding prices and possible discounts, please contact Guillaume Alonso on g.alonso@oxfordglobal.co.uk or call +44 (0)1865 248 455.
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.